Shantel L Duffy1, Jim Lagopoulos2, Ian B Hickie1, Keri Diamond1, Manuel B Graeber3, Simon J G Lewis1, Sharon L Naismith4. 1. Ageing Brain Centre , Brain & Mind Research Institute, The University of Sydney, Camperdown, Australia; Clinical Research Unit, Brain & Mind Research Institute, The University of Sydney, Camperdown, Australia. 2. Clinical Research Unit, Brain & Mind Research Institute, The University of Sydney, Camperdown, Australia. 3. Ken Parker Research Laboratories, Brain & Mind Research Institute, The University of Sydney, Camperdown, Australia. 4. Ageing Brain Centre , Brain & Mind Research Institute, The University of Sydney, Camperdown, Australia; Clinical Research Unit, Brain & Mind Research Institute, The University of Sydney, Camperdown, Australia. Electronic address: sharon.naismith@sydney.edu.au.
Abstract
BACKGROUND: Mild cognitive impairment (MCI) represents an at-risk state for Alzheimer's disease in which underlying pathophysiological mechanisms could be delineated. Oxidative stress has been implicated in Alzheimer's disease and can be measured by levels of the antioxidant glutathione. This study aims to assess in vivo levels of glutathione via proton magnetic resonance spectroscopy in patients with MCI and to determine how glutathione relates to cognitive decline. METHODS: Fifty-four patients with MCI and 41 healthy control subjects underwent proton magnetic resonance spectroscopy in conjunction with medical, psychiatric, and neuropsychological assessments. The concentration of glutathione was measured in the anterior and posterior cingulate, and ratios of glutathione were calculated relative to creatine. Neuropsychological performance was assessed across the domains of processing speed, learning, memory, and executive functions. RESULTS: In comparison with control subjects, patients with MCI had significantly elevated ratios of glutathione in the anterior (t = -2.2, P = .03) and posterior (t = -2.9, P = .005) cingulate. Higher levels of anterior cingulate glutathione were related to neuropsychological decrements on tests of executive functions. Elevated posterior cingulate glutathione was associated with poorer memory consolidation. CONCLUSION: This study has shown for the first time that MCI is associated with increased glutathione in the cingulate, which in turn relates to neuropsychological performance. This finding may be indicative of an early compensatory or neuroprotective response, and the role of glial cells and glutathione enzymes requires delineation. Longitudinal studies examining the utility of glutathione as a marker for cognitive decline are now required.
BACKGROUND: Mild cognitive impairment (MCI) represents an at-risk state for Alzheimer's disease in which underlying pathophysiological mechanisms could be delineated. Oxidative stress has been implicated in Alzheimer's disease and can be measured by levels of the antioxidant glutathione. This study aims to assess in vivo levels of glutathione via proton magnetic resonance spectroscopy in patients with MCI and to determine how glutathione relates to cognitive decline. METHODS: Fifty-four patients with MCI and 41 healthy control subjects underwent proton magnetic resonance spectroscopy in conjunction with medical, psychiatric, and neuropsychological assessments. The concentration of glutathione was measured in the anterior and posterior cingulate, and ratios of glutathione were calculated relative to creatine. Neuropsychological performance was assessed across the domains of processing speed, learning, memory, and executive functions. RESULTS: In comparison with control subjects, patients with MCI had significantly elevated ratios of glutathione in the anterior (t = -2.2, P = .03) and posterior (t = -2.9, P = .005) cingulate. Higher levels of anterior cingulate glutathione were related to neuropsychological decrements on tests of executive functions. Elevated posterior cingulate glutathione was associated with poorer memory consolidation. CONCLUSION: This study has shown for the first time that MCI is associated with increased glutathione in the cingulate, which in turn relates to neuropsychological performance. This finding may be indicative of an early compensatory or neuroprotective response, and the role of glial cells and glutathione enzymes requires delineation. Longitudinal studies examining the utility of glutathione as a marker for cognitive decline are now required.
Authors: Georg Oeltzschner; S Andrea Wijtenburg; Mark Mikkelsen; Richard A E Edden; Peter B Barker; Jin Hui Joo; Jeannie-Marie S Leoutsakos; Laura M Rowland; Clifford I Workman; Gwenn S Smith Journal: Neurobiol Aging Date: 2018-09-27 Impact factor: 4.673
Authors: Inga K Koerte; Alexander P Lin; Marc Muehlmann; Sai Merugumala; Huijun Liao; Tyler Starr; David Kaufmann; Michael Mayinger; Denise Steffinger; Barbara Fisch; Susanne Karch; Florian Heinen; Birgit Ertl-Wagner; Maximilian Reiser; Robert A Stern; Ross Zafonte; Martha E Shenton Journal: J Neurotrauma Date: 2015-05-14 Impact factor: 5.269
Authors: Archana Asundi; Yvonne Robles; Tyler Starr; Alan Landay; Jennifer Kinslow; Joshua Ladner; Laura White; Rebeca M Plank; Kathleen Melbourne; Daniel Weisholtz; Monica Bennett; Hong Pan; Emily Stern; Alexander Lin; Daniel R Kuritzkes; Nina H Lin Journal: J Acquir Immune Defic Syndr Date: 2019-08-15 Impact factor: 3.731
Authors: G C Chiang; X Mao; G Kang; E Chang; S Pandya; S Vallabhajosula; R Isaacson; L D Ravdin; D C Shungu Journal: AJNR Am J Neuroradiol Date: 2017-03-24 Impact factor: 3.825
Authors: Michael L Alosco; Yorghos Tripodis; Benjamin Rowland; Alicia S Chua; Huijun Liao; Brett Martin; Johnny Jarnagin; Christine E Chaisson; Ofer Pasternak; Sarina Karmacharya; Inga K Koerte; Robert C Cantu; Neil W Kowall; Ann C McKee; Martha E Shenton; Richard Greenwald; Michael McClean; Robert A Stern; Alexander Lin Journal: Brain Imaging Behav Date: 2020-10 Impact factor: 3.978
Authors: Shantel L Duffy; Jim Lagopoulos; Zoe Terpening; Simon J G Lewis; Ron Grunstein; Loren Mowszowski; Nathan Cross; Daniel F Hermens; Ian B Hickie; Sharon L Naismith Journal: Sleep Date: 2016-04-01 Impact factor: 5.849
Authors: Tao Song; Xiaopeng Song; Chenyawen Zhu; Regan Patrick; Miranda Skurla; Isabella Santangelo; Morgan Green; David Harper; Boyu Ren; Brent P Forester; Dost Öngür; Fei Du Journal: Ageing Res Rev Date: 2021-10-29 Impact factor: 10.895
Authors: Qianyun Chen; Jill Abrigo; Wanting Liu; Elyia Yixun Han; David Ka Wai Yeung; Lin Shi; Lisa Wing Chi Au; Min Deng; Sirong Chen; Eric Yim Lung Leung; Chi Lai Ho; Vincent Chung Tong Mok; Winnie Chiu Wing Chu Journal: Brain Sci Date: 2022-05-31
Authors: Nicole L Cockayne; Shantel L Duffy; Rosalind Bonomally; Amelia English; Paul G Amminger; Andrew Mackinnon; Helen M Christensen; Sharon L Naismith; Ian B Hickie Journal: Trials Date: 2015-06-03 Impact factor: 2.279